1. Home
  2. APYX vs IMUX Comparison

APYX vs IMUX Comparison

Compare APYX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.86

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.62

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
IMUX
Founded
1982
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.0M
85.8M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
APYX
IMUX
Price
$3.86
$0.62
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$8.00
$6.00
AVG Volume (30 Days)
120.9K
1.2M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,902,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.56
52 Week High
$4.44
$1.39

Technical Indicators

Market Signals
Indicator
APYX
IMUX
Relative Strength Index (RSI) 51.41 36.87
Support Level $3.92 $0.66
Resistance Level $4.14 $0.70
Average True Range (ATR) 0.19 0.04
MACD -0.05 -0.00
Stochastic Oscillator 15.22 1.40

Price Performance

Historical Comparison
APYX
IMUX

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: